Meet The Professors: 2008 Volume 1, Issue 1
A case-based discussion on the management
of
gastrointestinal stromal tumors
Editor: |
|
|
|
Neil Love, MD |
|
|
Faculty: |
|
|
Charles D Blanke, MD |
Brian Rubin, MD, PhD |
|
George D Demetri, MD |
Jonathan C Trent, MD, PhD |
|
Burton L Eisenberg, MD |
|
|
|
CME INFORMATION
FACULTY AFFILIATIONS AND DISCLOSURES
Cases 1 and 2 (from the practice of William N Harwin, MD) |
|
Primary GIST: Risk stratification
Epidemiology of GIST
Primary GIST: Clinical trials of adjuvant imatinib
Primary GIST: Clinical use of adjuvant imatinib |
Case 3 (from the practice of Malek Safa, MD) |
|
Metastatic GIST: Treatment for liver-only metastases
Metastatic GIST: Clinical use of neoadjuvant imatinib for liver-only metastases |
Case 4 (from the practice of Lowell Hart, MD) |
|
Metastatic GIST: Significance of exon 9 mutations
Metastatic GIST: Mechanisms of resistance to imatinib
Metastatic GIST: Sunitinib as second-line therapy |
Case 8 (from the practice of Sushil Bhardwaj, MD) |
|
Metastatic GIST: Salvage surgery for patients with disease progression on imatinib
Metastatic GIST: Tolerability and efficacy of sunitinib
Metastatic GIST: Novel therapies
Metastatic GIST: Testing for exon 9 mutations |
Case 9 (from the practice of Philip T Glynn, MD) |
|
Primary GIST: Duration of therapy with adjuvant imatinib |
Select Publications |
|